Loading patent…
AssigneeThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
InventorsSathibalan Ponniah, George E. Peoples, Catherine Storrer
Estimating the term…
The human HLA-A2:1g dimer molecule is a recombinant protein comprising a mouse IgG antibody fused with two human MHC Class I HLA-A2 molecules. Any peptide (usually 8-10 amino acids in length) can be loaded into the peptide-binding groove of the two HLA molecules, for example, by incubating a mixture of the dimer and peptide solution overnight. The resulting N peptide-specific HLA-A2:1g dimer mixture can then be added to PBMCs from peripheral blood samples in order to detect CD8 T lymphocytes which express T cell receptors that are capable of specifically interacting with and binding to the peptide HLA-A2:1g dimer molecules. The presence of such specific binding activity and interactions can then be detected by additional staining with fluorescence-conjugated antibodies.
A method of monitoring an immune response to a test peptide, the method comprising:
A method of monitoring an immune response to a test peptide, the method comprising:
A kit comprising a fusion protein comprising a mouse immunoglobulin fused to two human MHC class I HLA molecules and a negative control peptide, wherein the negative control peptide is an E37 peptide having the amino acid sequence RIAWARTEL (SEQ ID NO:4).
Dependencies are inferred from the claim text.